Treatment for Breast Cancer

Phase-Based Progress Estimates
Case Comprehensive Cancer Center, Cleveland, OH
Breast Cancer+2 More
All Sexes
What conditions do you have?

Study Summary

This study is evaluating whether giving people more time or other resources helps them remember more and more accurate details about their cancer screening and care.

See full description

Eligible Conditions

  • Breast Cancer
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

This trial is evaluating whether Treatment will improve 2 primary outcomes in patients with Breast Cancer. Measurement will happen over the course of at 1 week (after second survey completed).

Week 1
Accuracy of survey
Completeness of survey

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Control Group
1 of 2
Intervention Group
1 of 2
Active Control

This trial requires 100 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Control GroupSurvey questions at baseline and at one week. The control group will have had one week to reflect on the questions, and investigators anticipate some influence of this on responses.
Intervention Group
The intervention group will be prompted about accessing their medical records from the major local health systems online, with links to directions provided by each hospital system. They will then be asked to fill out the same questionnaire.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at 1 week (after second survey completed)
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly at 1 week (after second survey completed) for reporting.

Closest Location

Case Comprehensive Cancer Center - Cleveland, OH

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
diagnosed with breast or prostate cancer within the last 10 years
have access to the internet with a working email address
reside in Northeast Ohio

Patient Q&A Section

Have there been other clinical trials involving treatment?

"The authors summarize the published data concerning treatments of prostate cancer, including radiotherapy, hormonal therapy, chemotherapy and targeted therapies. They emphasize the need for more rigorous studies aimed at evaluating the efficacy of these different therapeutic approaches." - Anonymous Online Contributor

Unverified Answer

What are common treatments for prostate cancer?

"Although many different therapies were analyzed, only two common treatments were identified – radical prostatectomy and radiotherapy. Radical prostatectomy was found to be the most frequently used treatment in 2011, despite its cumulative positive outcomes. Radiotherapy was found to be less frequently used than previously reported, but still remains the standard treatment for localized prostate cancer, particularly in younger and healthier men." - Anonymous Online Contributor

Unverified Answer

What are the chances of developing prostate cancer?

"Prostatic carcinoma can develop at any age. However, prostate cancer develops most commonly between ages 50 and 70 years. Men's risk of developing prostate cancer appears higher after the age of 40 years than before that time. A larger number of men begin to develop prostate cancer after their fiftieth birthday. As many as half of all men over age 70 will have prostate cancer sometime during their lives. The average interval between first diagnosis of prostate cancer and death from the disease is 6–8 years." - Anonymous Online Contributor

Unverified Answer

What does treatment usually treat?

"We found no evidence that current treatments for BPH are ineffective. Although treatment does have some side effects, we found no evidence that those side effects are excessive compared to the risks associated with untreated disease. Furthermore, the treatment options available for BPH do not appear to be more effective than those available for symptomatic prostate cancer." - Anonymous Online Contributor

Unverified Answer

How many people get prostate cancer a year in the United States?

"Although this study only covers the period 2003-2008, it suggests that more than 830,000 men will be diagnosed with prostate cancer before they die in 2005, and more than 1.2 million men will be diagnosed before they die in 2007. This is more than double the number reported in 1960. Even though these numbers are based solely on deaths due to prostate cancer, they still suggest that almost 3 million men in the U.S. will be diagnosed with prostate cancer during the years 2006-2007. A significant proportion of these men will be diagnosed at an advanced stage where treatment options are limited. These statistics emphasize the need for earlier detection of prostate cancer, especially among men who are uninsured or underinsured." - Anonymous Online Contributor

Unverified Answer

What are the latest developments in treatment for therapeutic use?

"Improvements in surgical approaches, radiation therapy, chemotherapy and hormonal therapy have led to a sharp increase in overall survival in patients diagnosed with [prostate cancer]( Although many of these therapies do not provide complete resolution of cancer symptoms, they have increased the proportion of men who can expect to live longer than 10 years after diagnosis." - Anonymous Online Contributor

Unverified Answer

How does treatment work?

"The two treatments showed equivalent outcomes after radical prostatectomy in terms of the PSA-recurrence rate, biochemical progression, and overall survival. However, operative therapy was costlier than radiotherapy." - Anonymous Online Contributor

Unverified Answer

How serious can prostate cancer be?

"In a recent study, less than half of the patients were treated surgically and only 32% of these men received adjuvant radiation therapy; yet, the cancer was confined to the prostate at radical surgery and to the prostate and seminal vesicles at radical surgery and/or radiation treatment." - Anonymous Online Contributor

Unverified Answer

Who should consider clinical trials for prostate cancer?

"Despite 20 yr of clinical trial experience with active surveillance among all age groups, patients are still hesitant to enroll in such studies. They believe that more information about the risks and benefits is needed before they decide whether to take part in these studies. Further efforts to educate patients regarding the value of clinical trials will be important to encourage participation." - Anonymous Online Contributor

Unverified Answer

Have there been any new discoveries for treating prostate cancer?

"Over the past decade, research efforts have focused on developing more effective treatments to control prostate cancer (e.g., targeting metastatic targets, inhibiting growth factors, and activating apoptotic pathways). Although most of these new therapies are still being developed, some of them are already being tested clinically. Notable examples of these agents include Trastuzumab, Oxaliplatin, and Zoledronic Acid. Despite advances in understanding the mechanisms of disease progression and therapy, the majority of patients do not respond to initial treatments and will eventually succumb to the disease." - Anonymous Online Contributor

Unverified Answer

Can prostate cancer be cured?

"Data from a recent study suggest that radical prostatectomy combined with adjuvant radiotherapy for clinically localized PCa can achieve excellent survival rates compared with standard treatment options and should be offered to all eligible patients regardless of grade or stage." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Breast Cancer by sharing your contact details with the study coordinator.